June 17, 2011 (Montreal, Quebec City) — In patients presenting with ACS, the newer echo technique of speckle tracking can help predict risk of death, researchers report [1]. This technique, which ...

Heart disease is the leading cause of adult death worldwide, making cardiovascular disease diagnosis and management a global ...

Recently, while preparing an updated presentation to the Saint Louis University cardiology fellows on "diastolic dysfunction," the Skeptical Cardiologist came across a document entitled "What Does ...

Advanced left ventricular diastolic dysfunction (LVDD) in patients undergoing TAVR is linked with almost a fourfold increase in risk of postprocedural death as early as 30 days postprocedure, ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...

Researchers developed a multiview AI model that analyzes multiple echocardiogram images simultaneously, improving detection of heart conditions, and capturing complex cardiac structure and function ...

VIENNA — A diet that was short on carbohydrates and long on protein, given to diabetic patients engaged in a supervised exercise and weight-loss program, appeared not only to cut proinsulin levels and ...

Men and women, aged 20–80 years, with a history of stage 1 or 2 essential hypertension (mean BP measurement of >140 mm Hg systolic or >90 mm Hg diastolic) were screened for inclusion by assessing ...

Orchestra BioMed Holdings, Inc. announced promising echocardiographic data regarding atrioventricular interval modulation (AVIM) therapy's impact on patients with diastolic dysfunction at the THT 2025 ...

heart failure, doppler CKD patients with and without diastolic dysfunction had average serum phosphate levels of 7.3 and 5.5 mg/dL, respectively. Hyperphosphatemia and high calcium-phosphorus product, ...

Left ventricular diastolic dysfunction is associated with worse health status among patients with severe aortic stenosis, but TAVR leads to clinically meaningful symptomatic improvements regardless of ...